Context Therapeutics

Quarterly Financials

Values in thousands 2024-09-30 2024-06-30 2024-03-31 2023-12-31
Revenue
$0
$0
$0
$18
Gross Profit
-2
-2
16
EBITDA
-18,698
-3,085
-3,820
-6,930
EBIT
-18,701
-3,088
-3,823
-6,933
Net Income
-17,459
-2,254
-3,667
-6,769
Net Change In Cash
0
0
0
18
Free Cash Flow
7,709
-3,355
-4,360
-7,227
Cash
84,801
101,536
10,089
14,449
Basic Shares
80,481
54,958
15,966
15,966

Annual Financials

Values in thousands 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Revenue
$0
$0
$0
$0
Gross Profit
-12
-9
EBITDA
-25,060
-14,826
-10,525
-2,572
EBIT
-25,072
-14,835
-7,437
-2,572
Net Income
-23,964
-14,290
-7,433
6,644
Net Change In Cash
0
0
0
0
Free Cash Flow
-21,047
-14,086
-9,049
-1,034
Cash
14,449
35,497
49,635
341
Basic Shares
15,966
15,966
15,966
10,959

Earnings Calls

Quarter EPS
2024-09-30
-$0.22
2024-06-30
-$0.04
2024-03-31
-$0.23
2023-12-31
-$0.42